Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease

Magnetic Resonance Imaging

Volumn 23, Issue 4, 2005, Pages 557-562

  Mastropasqua, Maria ^a,c   Braga, Larissa ^a   Kanematsu, Masayuki ^a,d   Vaidean, Georgeta ^b   Shrestha, Roshan ^a   Leonardou, Polytimi ^a   Firat, Zeynep ^a   Woosley, John T ^a   Semelka, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hepatocellular carcinoma; Liver; Liver cirrhosis; Liver tumors; MR

Indexed keywords

ALCOHOL; GADOLINIUM;

ADULT; AGED; ALCOHOL ABUSE; CONFIDENCE INTERVAL; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; FEMALE; HEALTH CENTER; HEMOCHROMATOSIS; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER NODULE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TUMOR VOLUME; VIRUS INFECTION;

HEPATITIS C VIRUS;

EID: 20344394669     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2005.02.001     Document Type: Article

References (34)

1. R.L. Carithers Jr. Liver transplant practice guidelines Liver Transpl 6 2000 122 135
2. N. Boyes, and P. Marcellin Pathogenesis, diagnosis and management of hepatitis C J Hepatol 32 2000 98 112
3. M.M. Hassan, A. Frome, Y.Z. Patt, and H.B. El-Serag Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States J Clin Gastroenterol 35 2002 266 269
4. B.P. Yawn, P. Wollan, L. Gazzuola, and W.R. Kim Diagnosis and 10-year follow up of a community-based hepatitis C cohort J Fam Pract 51 2002 135 140
5. Y. Yamashita, K. Mitsuzaki, T. Yi, I. Ogata, T. Nishiharu, and J. Urata Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver Radiology 200 1 1996 79 84
6. R.C. Semelka, S. Worawattanakul, N.L. Kelekis, G. John, J.T. Woosley, and M. Graham Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques J Magn Reson Imaging 7 6 1997 1040 1047
7. R.C. Semelka, D.R. Martin, C. Balci, and T. Lance Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement J Magn Reson Imaging 13 3 2001 397 401
8. E.S. Siegelman, D.G. Mitchell, E. Outwater, S.J. Munoz, and R. Rubin Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients Radiology 188 1993 637 641
9. A.J. Czaja, and D.K. Freese Diagnosis and treatment of autoimmune hepatitis Hepatology 36 2002 479 497
10. J.S. Wenzel, A. Donohoe, K.L. Ford III, K. Glastad, D. Watkins, and E. Molmenti Primary biliary cirrhosis: MR imaging findings and description of MR imaging periportal halo sign AJR Am J Roentgenol 176 2001 885 889
11. T.R. Bader, K.L. Beavers, and R.C. Semelka MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease Radiology 226 2003 675 685
12. E. Bugianesi, N. Leone, E. Vanni, G. Marchesini, F. Brunello, and P. Carucci Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140
13. J.P. Earls, N.D. Theise, J.C. Weinreb, D.R. DeCorato, G.A. Krinsky, and N.M. Rofsky Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation Radiology 201 1996 207 214
14. G.A. Krinsky, V.S. Lee, N.D. Theise, J.C. Weinreb, N.M. Rofsky, and T. Diflo Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation Radiology 219 2001 445 454
15. J. Ward, J.A. Guthrie, D.J. Scott, J. Atchley, D. Wilson, and M.H. Davies Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis Radiology 216 2000 154 162
16. N.L. Kelekis, R.C. Semelka, S. Worawattanakul, E.E. de Lange, S.M. Ascher, and I.O. Ahn Hepatocellular carcinoma in North America: a multi-institutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images AJR Am J Roentgenol 170 1998 1005 1013
17. J. Rakela, and H.E. Vagas Hepatitis C: magnitude of the problem Liver Transpl 8 10 Suppl 1 2002 S3 S6
18. M. Alter, D. Kruszon-Moran, and O.V. Nainan The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
19. G. McQuillan, M. Alter, L. Moyer, S. Lambert, and H. Margolis A population-based serologic study of hepatitis C virus infection in the United States Am J Epidemiol 146 Suppl 1996 S32
20. Y. Yamagishi, Y. Horie, and M. Kajihara Hepatocellular carcinoma in heavy drinkers with negative markers for viral hepatitis Hepatol Res 28 2004 177 183
21. G.E. Gondolesi, S. Roayaie, and L. Munoz Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria Ann Surg 239 2004 142 149
22. H.B. El-Serag Hepatocellular carcinoma and hepatitis C in the United States Hepatology 36 2002 S74 S83
23. J.M. Yuan, S. Govindarajan, K. Arakawa, and M.C. Yu Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101 2004 1009 1017
24. D. Byron, and G.Y. Minuk Clinical hepatology: profile of an urban, hospital-based practice Hepatology 24 4 1996 813 815
25. M. Greeve, L. Ferrell, M. Kim, C. Combs, J. Roberts, and N. Ascher Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes Hepatology 17 4 1993 593 598
26. J.C. Sheu, J.L. Sung, and D.S. Chen Growth rate of asymptomatic HCC and its clinical implications Gastroenterology 89 1985 257 266
27. J.A. Marrero, R.J. Fontana, G.L. Su, H.S. Conjeevaram, D.M. Emick, and A.S. Lok NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States Hepatology 36 6 2002 1349 1354
28. H.B. El-Serag Hepatocellular carcinoma: an epidemiologic view J Clin Gastroenterol 35 5 Suppl 2 2002 S72 S78
29. M.M. Hassan, L.Y. Hwang, C.J. Hatten, M. Swaim, D. Li, and J.L. Abbruzzese Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus Hepatology 36 5 2002 1206 1213
30. M.S. Peterson, R.L. Baron, J.W. Marsh Jr., J.H. Oliver III, S.R. Confer, and L.E. Hunt Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation Radiology 217 3 2000 743 749
31. C. Niederau, A. Erhardt, D. Haussinger, and G. Strohmeyer Haemochromatosis and the liver J Hepatol 30 Suppl 1 1999 6 11
32. A. Shibuya, K. Tanaka, H. Miyakawa, M. Shibata, M. Takatori, and K. Sekiyama Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis Hepatology 35 2002 1172 1178
33. S. Govindarajan, M. Ashcavai, and R.L. Peters Alpha-1-antitrypsin phenotypes in hepatocellular carcinoma Hepatology 1 1981 628 631
34. J.F. Renz, and N.L. Asher Liver transplantation for nonviral, nonmalignant diseases: problem of current World J Surg 26 2002 247 256